Sign up for a free trial now

Login
Subscribe
Take a FREE Trial

About Us
Contact us
RSS

26 May 2013

Search

The Pharma Letter

Home
7 Day Premium Trial
Pharmaceuticals
Biotechnology
Generics
Events
Companies
Drugs
Subscribe

Alembic Pharmaceuticals Articles

Ranbaxy in deal with Alembic to market bioequivalent Pristiq in USA

5 March 2013

Showing 1-1 of 1 articles

Go to beginning

Previous

1

Next

Go to end

Hot Topics
Most Read

Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
Proposal to list Roche's Neulastim and Actemra in New Zealand
Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth

Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
Proposal to list Roche's Neulastim and Actemra in New Zealand
Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth

© 2013 thepharmaletter.com

Home
RSS
About Us
Subscribe
Terms and Conditions
Article Archive

Site powered by WORKSsitebuilder CMS